Postmarketing drug surveillance and death by committee

被引：1
|
作者：
Lyles, Alan
机构：
来源：
CLINICAL THERAPEUTICS | 2006年 / 28卷 / 06期
关键词：
D O I：
10.1016/j.clinthera.2006.06.005
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：962 / 963
页数：2
相关论文
共 50 条
  • [1] POSTMARKETING DRUG SURVEILLANCE
    BORDEN, EK
    GARDNER, JS
    WESTLAND, MM
    GARDNER, SD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (06): : 729 - 729
  • [2] POSTMARKETING DRUG SURVEILLANCE
    FELDMANN, EG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (12) : R1 - R1
  • [3] A POTENTIAL USE OF THE NATIONAL DEATH INDEX FOR POSTMARKETING DRUG SURVEILLANCE
    EDLAVITCH, SA
    FEINLEIB, M
    ANELLO, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (09): : 1292 - 1295
  • [4] THE IMPORTANCE OF POSTMARKETING DRUG SURVEILLANCE
    SMART, AJ
    WALTERS, L
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1992, 82 (06): : 383 - 384
  • [5] Postmarketing surveillance for drug abuse
    Arfken, CL
    Cicero, TJ
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) : S97 - S105
  • [6] WORLDWIDE POSTMARKETING DRUG SURVEILLANCE
    VENULET, J
    [J]. REVUE DE MEDECINE INTERNE, 1986, : 52 - 56
  • [7] Postmarketing surveillance for drug safety
    Holden, WL
    Scarazzini, LJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 503 - 503
  • [8] POSTMARKETING DRUG SURVEILLANCE STUDIES
    FAICH, GA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (05) : 597 - 597
  • [9] Using drug courts for drug postmarketing surveillance
    Griffin, O. Hayden, III
    Woodward, Vanessa H.
    [J]. DRUGS AND ALCOHOL TODAY, 2016, 16 (02) : 165 - 175
  • [10] Postmarketing surveillance for drug safety - Reply
    Griffin, MR
    Stein, CM
    Ray, WA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 504 - 505
12345